@FiercePharma: Tension rises for pharma in China as court reportedly fines J&J, officials visit Sanofi. ICYMI yesterday | Follow @FiercePharma
@CarlyHFierce: More bribery allegations in China, these ones against Baxter (and just now surfacing from last year). News | Follow @CarlyHFierce
> CVS Caremark ($CVS) says it will pay a $20 million civil penalty to settle SEC allegations that it made inappropriate public disclosures in 2011 about problems in some units. Story
> Companies that sell prescription acetaminophen will be required to add a warning about the risk of potentially deadly rashes and blistering of the skin, the FDA said Thursday. News
> Mylan ($MYL) has let the markets know that it expects is sales to fall at the low end of its 2013 forecast of $7 billion to $7.4 billion. Report
> Indian generics maker Lupin says the FDA has approved its generic of Gilead Sciences' ($GILD) heart drug, Ranexa. More
@FierceMedDev: Trending on FierceMedicalDevices.com: Covidien watches profits slide after kicking drugs. Article | Follow @FierceMedDev
@MarkHFierce: House Republican freshmen are pressing hard for a vote on a device tax repeal bill. Item | Follow @MarkHFierce
@DamianFierce: Now the Senate is getting in on the push to spare FDA user fees from sequester cuts. Story | Follow @DamianFierce
@MichaelGFierce: Trending on FierceDrugDelivery.com: Swedish team creates 'impossible' record-breaking drug delivery material. Article | Follow @MichaelGFierce
> Smith & Nephew has $1.5B and eyes on M&A. More
> J&J's DePuy, fearing fracture or limb-loss risks, recalls orthopedic implant part. News
> Report: ICU Medical nears sale that could top $1B. Article
Biotech News
@FierceBiotech: Industry Voices: The Zero-Person Biotech Company. Item | Follow @FierceBiotech
@JohnCFierce: Biotech's IPO boom extends its streak through a blistering July. Report | Follow @JohnCFierce
@RyanMFierce: Didn't take the lawyers long to start fishing for angry Optimer shareholders after Cubist buyout announced Tuesday. Release | Follow @RyanMFierce
@EmilyMFierce: NIH team sees diabetes drug as a possible tool for extending life. Story | Follow @EmilyMFierce
> Survey: Americans say cancer should be top priority for medical research. Story
> Stem cell transplants show potential in patients with extremely rare brain disease. More
> Baxter caught up in China bribery scandal. Item
And Finally... Shire ($SHPG) has settled an age discrimination lawsuit by the former head of its Regenerative Medicine unit. Story